US45784P1012
US45784P1012
Insulet Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.38B EUR | 10.56B EUR | 14.53B EUR | 20.01B EUR |
Enterprise Value | 9.74B EUR | 10.97B EUR | 15B EUR | 20.24B EUR |
Valuation Multiples | ||||
Trailing P/E | 25.19x | 28.13x | 48x | 94.51x |
Forward P/E | 17.5x | -- | -- | -- |
Price to Sales | 3.07x | 3.46x | 5.01x | 9.35x |
Price to Book | 6.6x | 7.42x | 11.16x | 13.2x |
EV/Revenue | 3.19x | 3.59x | 5.17x | 9.46x |
EV/EBITDA | 15.84x | 17.14x | 23.59x | 41.99x |
Price to FCF (P/FCF) | 39.6x | 39.75x | 37.48x | 66.3x |
EV/FCF | 41.11x | 41.31x | 38.68x | 67.07x |
FCF Yield | 2.52% | 2.52% | 2.67% | 1.51% |